Abbas, O. L., Ozatik, O., Gonen, Z. B., Ogut, S., Ozatik, F. Y., Salkin, H., et al. (2019). Comparative analysis of mesenchymal stem cells from bone marrow, adipose tissue, and dental pulp as sources of cell therapy for zone of stasis burns. J. Investigative Surg. 32 (6), 477–490. doi:10.1080/08941939.2018.1433254
Ben-David, U., and Benvenisty, N. (2011). The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11 (4), 268–277. doi:10.1038/nrc3034
Chen, S. R., Ding, S. H., Yin, Y. B., Xu, L., Li, P. F., Peppelenbosch, M. P., et al. (2019). Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication. Antivir. Res. 167, 35–44. doi:10.1016/j.antiviral.2019.04.005
Choi, K. M., Seo, Y. K., Yoon, H. H., Song, K. Y., Kwon, S. Y., Lee, H. S., et al. (2007). Effects of mechanical stimulation on the proliferation of bone marrow-derived human mesenchymal stem cells. Biotechnol. Bioprocess Eng. 12 (6), 601–609. doi:10.1007/ bf02931075
Christian, S., Merz, C., Evans, L., Gradl, S., Seidel, H., Friberg, A., et al. (2019). The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia 33 (10), 2403–2415. doi:10.1038/s41375-019-0461-5
Desler, C., Lykke, A., and Rasmussen, L. J. (2010). The effect of mitochondrial dysfunction on cytosolic nucleotide metabolism. J. Nucleic Acids 2010, 701518. doi:10. 4061/2010/701518
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (4), 315–317. doi:10.1080/14653240600855905
Dorasamy, M. S., Choudhary, B., Nellore, K., Subramanya, H., and Wong, P. F. (2017). Dihydroorotate dehydrogenase inhibitors target c-myc and arrest melanoma, myeloma and lymphoma cells at S-phase. J. Cancer 8 (15), 3086–3098. doi:10.7150/jca.14835
Dubail, J., and Apte, S. S. (2015). Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. Matrix Biol. 44-46, 24–37. doi:10.1016/j.matbio.2015. 03.001
Duncan, G. S., Andrew, D. P., Takimoto, H., Kaufman, S. A., Yoshida, H., Spellberg, J., et al. (1999). Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162 (5), 3022–3030. doi:10.4049/ jimmunol.162.5.3022
Duran, J. M., Makarewich, C. A., Sharp, T. E., Starosta, T., Zhu, F., Hoffman, N. E., et al. (2013). Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circulation Res. 113 (5), 539–552. doi:10.1161/CIRCRESAHA.113.301202
Eto, S., Goto, M., Soga, M., Kaneko, Y., Uehara, Y., Mizuta, H., et al. (2018). Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials. Plos One 13 (7), e0200790. doi:10.1371/journal.pone.0200790
Fornace, A. J., Nebert, D. W., Hollander, M. C., Luethy, J. D., Papathanasiou, M., Fargnoli, J., et al. (1989). Mammalian genes coordinately regulated by growth arrest signals and dna-damaging agents. Mol. Cell. Biol. 9 (10), 4196–4203. doi:10.1128/mcb.9.10.4196
Frank, V., Kaufmann, S., Wright, R., Horn, P., Yoshikawa, H. Y., Wuchter, P., et al. (2016). Frequent mechanical stress suppresses proliferation of mesenchymal stem cells from human bone marrow without loss of multipotency. Sci. Rep. 6, 24264. doi:10.1038/ srep24264
Han, Y., Li, X. Z., Zhang, Y. B., Han, Y. P., Chang, F., and Ding, J. X. (2019). Mesenchymal stem cells for regenerative medicine. Cells 8 (8), 886. doi:10.3390/ cells8080886
Harada, A., Goto, M., Kato, A., Takenaka-Ninagawa, N., Tanaka, A., Noguchi, S., et al. (2021). Systemic supplementation of collagen VI by neonatal transplantation of iPSC- derived MSCs improves histological phenotype and function of col6-deficient model mice. Front. Cell Dev. Biol. 9, 790341. doi:10.3389/fcell.2021.790341
Hentze, H., Soong, P. L., Wang, S. T., Phillips, B. W., Putti, T. C., and Dunn, N. R. (2009). Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res. 2 (3), 198–210. doi:10.1016/j.scr. 2009.02.002
Jones, B. J., and McTaggart, S. J. (2008). Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp. Hematol. 36 (6), 733–741. doi:10.1016/j.exphem.2008. 03.006
Kamiya, D., Takenaka-Ninagawa, N., Motoike, S., Kajiya, M., Akaboshi, T., Zhao, C., et al. (2022). Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineage. npj Regen. Med. 7 (1), 47. doi:10.1038/s41536-022-00241-8
Kawase, T., Ohki, R., Shibata, T., Tsutsumi, S., Kamimura, N., Inazawa, J., et al. (2009). PH domain-only protein PHLDA3 is a p53-regulated repressor of akt. Cell 136 (3), 535–550. doi:10.1016/j.cell.2008.12.002
Kimura, Y., Shofuda, T., Higuchi, Y., Nagamori, I., Oda, M., Nakamori, M., et al. (2019). Human genomic safe harbors and the suicide gene-based safeguard system for iPSC-based cell therapy. Stem Cells Transl. Med. 8 (7), 627–638. doi:10.1002/sctm.18- 0039
Kondo, T. (2021). Selective eradication of pluripotent stem cells by inhibitingDHODHactivity. Stem Cells 39 (1), 33–42. doi:10.1002/stem.3290
Kozlowska, U., Krawczenko, A., Futoma, K., Jurek, T., Rorat, M., Patrzalek, D., et al. (2019). Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues. World J. Stem Cells 11 (6), 347–374. doi:10. 4252/wjsc.v11.i6.347
Kuroda, T., Yasuda, S., Kusakawa, S., Hirata, N., Kanda, Y., Suzuki, K., et al. (2012). Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. Plos One 7 (5), e37342. doi:10.1371/ journal.pone.0037342
Lafita-Navarro, M. C., Venkateswaran, N., Kilgore, J. A., Kanji, S., Han, J., Barnes, S., et al. (2020). Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells. Plos Genet. 16 (11), e1009117. doi:10.1371/journal.pgen.1009117
Liang, B., Chen, J. H., Li, T., Wu, H. Y., Yang, W. J., Li, Y. J., et al. (2020). Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells A case report. Medicine 99 (31), e21429. doi:10.1097/MD. 0000000000021429
Love, M. I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15 (12), 550. doi:10.1186/s13059- 014-0550-8
Masuda, S., Yokoo, T., Sugimoto, N., Doi, M., Fujishiro, S., Takeuchi, K., et al. (2012). A simplified in vitro teratoma assay for pluripotent stem cells injected into rodent fetal organs. Cell Med. 3 (1-3), 103–112. doi:10.3727/215517912X639351
Nagashima, T., Shimizu, K., Matsumoto, R., and Honda, H. (2018). Selective elimination of human induced pluripotent stem cells using medium with high concentration of L-alanine. Sci. Rep. 8, 12427. doi:10.1038/s41598-018-30936-2
Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., et al. (2014). A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594. doi:10.1038/srep03594
Ohgushi, M., Matsumura, M., Eiraku, M., Murakami, K., Aramaki, T., Nishiyama, A., et al. (2010). Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7 (2), 225–239. doi:10.1016/ j.stem.2010.06.018
Sarkar, R. R., Gloude, N. J., Schiff, D., and Murphy, J. D. (2019). Cost-effectiveness of chimeric antigen receptor T-cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. Jnci-Journal Natl. Cancer Inst. 111 (7), 719–726. doi:10.1093/jnci/ djy193
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., et al. (2012). Fiji: An open-source platform for biological-image analysis. Nat. Methods 9 (7), 676–682. doi:10.1038/nmeth.2019
Shammaa, R., El-Kadiry, A. E., Abusarah, J., and Rafei, M. (2020). Mesenchymal stem cells beyond regenerative medicine. Front. Cell Dev. Biol. 8, 72. doi:10.3389/fcell.2020.00072
Spitzhorn, L. S., Megges, M., Wruck, W., Rahman, M. S., Otte, J., Degistirici, O., et al. (2019). Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. Stem Cell Res. Ther. 10, 100. doi:10.1186/s13287-019-1209-x
Tanosaki, S., Tohyama, S., Fujita, J., Someya, S., Hishiki, T., Matsuura, T., et al. (2020). Fatty acid synthesis is indispensable for survival of human pluripotent stem cells. Iscience 23 (9), 101535. doi:10.1016/j.isci.2020.101535
Walter, M., and Herr, P. (2022). Re-discovery of pyrimidine salvage as target in cancer therapy. Cells 11 (4), 739. doi:10.3390/cells11040739
Weyd, H., Abeler-Dorner, L., Linke, B., Mahr, A., Jahndel, V., Pfrang, S., et al. (2013). Annexin A1 on the surface of early apoptotic cells suppresses CD8(+) T cell immunity. Plos One 8 (4), e62449. doi:10.1371/journal.pone.0062449
Wobma, H. M., Kanai, M., Ma, S. P., Shih, Y., Li, H. W., Duran-Struuck, R., et al. (2018). Dual IFN-γ/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms. J. Immunol. Regen. Med. 1, 45–56. doi:10.1016/j.regen.2018.01.001
Wu, Y. J., Chen, L., Scott, P. G., and Tredget, E. E. (2007). Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25 (10), 2648–2659. doi:10.1634/stemcells.2007-0226
Xu, X. L., Williams, J. W., Shen, J. K., Gong, H. H., Yin, D. P., Blinder, L., et al. (1998). In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J. Immunol. 160 (2), 846–853. doi:10.4049/jimmunol.160.2.846
Yamamoto, T., Takenaka, C., Yoda, Y., Oshima, Y., Kagawa, K., Miyajima, H., et al. (2018). Differentiation potential of pluripotent stem cells correlates to the level of CHD7. Sci. Rep. 8, 241. doi:10.1038/s41598-017-18439-y
Yang, D. D., Chen, Z. H., Yu, K., Lu, J. H., Wu, Q. N., Wang, Y., et al. (2020). METTL3 promotes the progression of gastric cancer via targeting the MYC pathway. Front. Oncol. 10, 115. doi:10.3389/fonc.2020.00115
Yang, H. L., Zhao, R. Y., and Lee, M. H. (2006). 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol. Cancer Ther. 5 (2), 253–260. doi:10. 1158/1535-7163.MCT-05-0395
Yoshimatsu, M., Ohnishi, H., Zhao, C., Hayashi, Y., Kuwata, F., Kaba, S., et al. (2021). In vivo regeneration of rat laryngeal cartilage with mesenchymal stem cells derived from human induced pluripotent stem cells via neural crest cells. Stem Cell Res. 52, 102233. doi:10.1016/j.scr.2021.102233
Zeller, K. I., Jegga, A. G., Aronow, B. J., O’Donnell, K. A., and Dang, C. V. (2003). An integrated database of genes responsive to the myc oncogenic transcription factor: Identification of direct genomic targets. Genome Biol. 4 (10), R69. doi:10.1186/gb- 2003-4-10-r69
Zhang, J., Chen, M. Z., Liao, J. Q., Chang, C. F., Liu, Y. Q., Padhiar, A. A., et al. (2021). Induced pluripotent stem cell-derived mesenchymal stem cells hold lower heterogeneity and great promise in biological research and clinical applications. Front. Cell Dev. Biol. 9, 716907. doi:10.3389/fcell.2021.716907
論文の公開元へ
